In Hong Kong, a global hub for medical excellence, OncoCare remains steadfast in its belief — that through efficient, knowledge-based integrated cancer diagnostics and personalized treatment, aim to add years and quality of life to all patients.
Led by several founding doctors, including Dr. Teo Man Lung Peter, Hong Kong Sanatorium Hospital Honorary Consultant in Clinical Oncology, and Dr. Chu Kin Wah, Colorectal Surgeon, alongside an experienced team of oncology and colorectal specialists, our clinics offer a wide range of treatment and care options for the Hong Kong community.
We operate two “OncoCare Cancer Centre”, offering inpatient and outpatient services, including in-house chemotherapy, providing treatment for all adult cancers. Our services include chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy and surgery that delivered alongside reputable hospital partners.
The other two “Tamarind Specialists Centre” provide comprehensive, one-stop care for colorectal diagnostics and surgery. The centre has also expanded its services to include specialties such as family medicine, breast surgery, respiratory medicine, etc., offering health screening and referral services, as well as diagnosis, treatment and surgical services for breast and respiratory diseases to the public.
Our centres provide a convenient, confidential and comfortable environment for patients and their loved ones, backed by advanced medical technology and an international standard of treatment delivered by a caring medical team.
Four centres in Central and Tsim Sha Tsui serve more than 20,000 patient visits annually, including international patients from across the region. We believe every patient deserves the best care. We strive to ensure that patients, and their families feel safe and supported during the most challenging of times.
In 2025, OncoCare Hong Kong joined Tamarind Health Group. Tamarind Health Group is Asia’s leading integrated oncology-focused group, with a presence in Singapore, China and Hong Kong, Malaysia, the Philippines, and Vietnam.